Distinguished in Waldenstrom Macroglobulinemia

Bruno Royer

Paris, FR 
Distinguished in Waldenstrom Macroglobulinemia
Paris, FR 
OverviewLocationsClinical Research

Overview

Bruno Royer practices in Paris, France. Mr. Royer is rated as a Distinguished expert by MediFind in the treatment of Waldenstrom Macroglobulinemia. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Secondary Immunodeficiency (SID), Bone Marrow Transplant, and Splenectomy.

His clinical research consists of co-authoring 111 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Waldenstrom Macroglobulinemia.

Gender
Male

Locations

Paris, France
Other Locations
Avenue Laënnec Salouël, 80054 Amiens Cedex 1, Amiens, 80054, France
Port-saint-louis-du-rhone, France
Limoges, France
C2i Santé, Cabinet De Consultants En Ingénierie De La Santé, 10 Rue Paul Langevin Parc D'Activités St Jacques II, Maxeville, 54320, France
Clichy-sous-bois, France
Rennes, France
Nancy, France
Nantes, France
Poitiers, France
Dijon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Prospective, Sequential Multiple Assignment, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia
Prospective, Sequential Multiple Assignment, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drugs: Methotrexate, Cyclophosphamide
Study Phase: Phase 2
A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial
A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial
Enrollment Status: Completed
Publish Date: July 05, 2023
Intervention Type: Procedure, Drug
Study Drug: Pomalidomide+Cyclophosphamide+Dexamethasone
Study Phase: Phase 2
A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma
A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma
Enrollment Status: Completed
Publish Date: March 17, 2023
Intervention Type: Drug
Study Drug: Lenalidomide and GA101
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

111 Total Publications

[Erratum to "Haematopoietic stem cell transplantation in the treatment of autoimmune diseases" [Rev. Med. Interne 29 (2008) 115-121]].
[Erratum to "Haematopoietic stem cell transplantation in the treatment of autoimmune diseases" [Rev. Med. Interne 29 (2008) 115-121]].
Journal: La Revue de medecine interne
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Royer's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile